Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Rob Pieters
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Physiology
Living Beings
Chemicals & Drugs
Anatomy
Procedures
Concepts & Ideas
Phenomena
Sign-in to see full Profile
Network (preview)
94
Veerman, Anjo
64
den Boer, Monique
59
Kaspers, G J L
54
van Wering, Elisabeth
33
Janka-Schaub, Gritta
29
Hählen, Karel
28
Meijerink, Jules
28
Beverloo, Berna
23
van Zantwijk, Christina
23
van den Heuvel-Eibrink, Marry
23
Peters, Godefridus
17
Kazemier, Karin
17
Creutzig, Ursula
16
Jansen, Gerrit
16
Zwaan, Christian
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Rob Pieters (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: van der Linden Marieke H; Valsecchi Maria Grazia; De Lorenzo Paola; Möricke Anja; Janka Gritta; Leblanc Thierry M; Felice Maria; Biondi Andrea; Campbell Myriam; Hann Ian; Rubnitz Jeffrey E; Stary Jan; Szczepanski Tomasz; Vora Ajay; Ferster Alina; Hovi Liisa; Silverman Lewis B; Pieters Rob
Outcome of congenital acute lymphoblastic leukemia treated on the Interfant-99 protocol.
Blood 2009;114(18):3764-8.
-
2009: Hulleman Esther; Broekhuis Mathilde J C; Pieters Rob; Den Boer Monique L
Pyruvate kinase M2 and prednisolone resistance in acute lymphoblastic leukemia.
Haematologica 2009;94(9):1322-4.
-
2009: Hartman A; te Winkel M L; van Beek R D; de Muinck Keizer-Schrama S M P F; Kemper H C G; Hop W C J; van den Heuvel-Eibrink M M; Pieters R
A randomized trial investigating an exercise program to prevent reduction of bone mineral density and impairment of motor performance during treatment for childhood acute lymphoblastic leukemia.
Pediatric blood & cancer 2009;53(1):64-71.
-
2009: van Beek Robert D; van den Heuvel-Eibrink Marry M; Hakvoort-Cammel Friederike G; van den Bos Cor; van der Pal Heleen J H; Krenning Eric P; de Rijke Yolande B; Pieters Rob; de Muinck Keizer-Schrama Sabine M P F
Bone mineral density, growth, and thyroid function in long-term survivors of pediatric Hodgkin's lymphoma treated with chemotherapy only.
The Journal of clinical endocrinology and metabolism 2009;94(6):1904-9.
-
2009: Van der Velden V H J; Corral L; Valsecchi M G; Jansen M W J C; De Lorenzo P; Cazzaniga G; Panzer-Grümayer E R; Schrappe M; Schrauder A; Meyer C; Marschalek R; Nigro L L; Metzler M; Basso G; Mann G; Den Boer M L; Biondi A; Pieters R; Van Dongen J J M;
Prognostic significance of minimal residual disease in infants with acute lymphoblastic leukemia treated within the Interfant-99 protocol.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2009;23(6):1073-9.
-
2009: Hollink Iris H I M; van den Heuvel-Eibrink Marry M; Zimmermann Martin; Balgobind Brian V; Arentsen-Peters Susan T C J M; Alders Marielle; Willasch Andre; Kaspers Gertjan J L; Trka Jan; Baruchel Andre; de Graaf Siebold S N; Creutzig Ursula; Pieters Rob; Reinhardt Dirk; Zwaan C Michel
Clinical relevance of Wilms tumor 1 gene mutations in childhood acute myeloid leukemia.
Blood 2009;113(23):5951-60.
-
2009: de Jonge Robert; Tissing Wim J E; Hooijberg Jan Hendrik; Jansen Gerrit; Kaspers Gertjan J L; Lindemans Jan; Peters Godefridus J; Pieters Rob
Polymorphisms in folate-related genes and risk of pediatric acute lymphoblastic leukemia.
Blood 2009;113(10):2284-9.
-
2009: Den Boer Monique L; van Slegtenhorst Marjon; De Menezes Renée X; Cheok Meyling H; Buijs-Gladdines Jessica G C A M; Peters Susan T C J M; Van Zutven Laura J C M; Beverloo H Berna; Van der Spek Peter J; Escherich Gaby; Horstmann Martin A; Janka-Schaub Gritta E; Kamps Willem A; Evans William E; Pieters Rob
A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study.
The lancet oncology 2009;10(2):125-34.
-
2009: Hollink I H I M; Zwaan C M; Zimmermann M; Arentsen-Peters T C J M; Pieters R; Cloos J; Kaspers G J L; de Graaf S S N; Harbott J; Creutzig U; Reinhardt D; van den Heuvel-Eibrink M M; Thiede C
Favorable prognostic impact of NPM1 gene mutations in childhood acute myeloid leukemia, with emphasis on cytogenetically normal AML.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2009;23(2):262-70.
-
2009: Hulleman Esther; Kazemier Karin M; Holleman Amy; VanderWeele David J; Rudin Charles M; Broekhuis Mathilde J C; Evans William E; Pieters Rob; Den Boer Monique L
Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells.
Blood 2009;113(9):2014-21.
-
2009: Schotte D; Chau J C K; Sylvester G; Liu G; Chen C; van der Velden V H J; Broekhuis M J C; Peters T C J M; Pieters R; den Boer M L
Identification of new microRNA genes and aberrant microRNA profiles in childhood acute lymphoblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2009;23(2):313-22.
-
2008: Pieters Rob; Appel Inge; Kuehnel Hans-Juergen; Tetzlaff-Fohr Iris; Pichlmeier Uwe; van der Vaart Inekee; Visser Eline; Stigter Rolinda
Pharmacokinetics, pharmacodynamics, efficacy, and safety of a new recombinant asparaginase preparation in children with previously untreated acute lymphoblastic leukemia: a randomized phase 2 clinical trial.
Blood 2008;112(13):4832-8.
-
2008: van Grotel Martine; van den Heuvel-Eibrink Marry M; van Wering Elisabeth R; van Noesel Max M; Kamps Willem A; Veerman Anjo J P; Pieters Rob; Meijerink Jules P P
CD34 expression is associated with poor survival in pediatric T-cell acute lymphoblastic leukemia.
Pediatric blood & cancer 2008;51(6):737-40.
-
2008: te Winkel Mariel L; Appel Inge M; Pieters Rob; van den Heuvel-Eibrink Marry M
Impaired dexamethasone-related increase of anticoagulants is associated with the development of osteonecrosis in childhood acute lymphoblastic leukemia.
Haematologica 2008;93(10):1570-4.
-
2008: Van Vlierberghe Pieter; Pieters Rob; Beverloo H Berna; Meijerink Jules P P
Molecular-genetic insights in paediatric T-cell acute lymphoblastic leukaemia.
British journal of haematology 2008;143(2):153-68.
-
2008: de Bont Judith M; Kros Johan M; Passier Monique M C J; Reddingius Roel E; Sillevis Smitt Peter A E; Luider Theo M; den Boer Monique L; Pieters Rob
Differential expression and prognostic significance of SOX genes in pediatric medulloblastoma and ependymoma identified by microarray analysis.
Neuro-oncology 2008;10(5):648-60.
-
2008: Appel I M; Kazemier K M; Boos J; Lanvers C; Huijmans J; Veerman A J P; van Wering E; den Boer M L; Pieters R
Pharmacokinetic, pharmacodynamic and intracellular effects of PEG-asparaginase in newly diagnosed childhood acute lymphoblastic leukemia: results from a single agent window study.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2008;22(9):1665-79.
-
2008: Haarman E G; Kaspers G J L; Pieters R; Rottier M M A; Veerman A J P
Circumvention of glucocorticoid resistance in childhood leukemia.
Leukemia research 2008;32(9):1417-23.
-
2008: Appel Inge M; Hop Wim C J; van Kessel-Bakvis Carla; Stigter Rolinda; Pieters Rob
L-Asparaginase and the effect of age on coagulation and fibrinolysis in childhood acute lymphoblastic leukemia.
Thrombosis and haemostasis 2008;100(2):330-7.
-
2008: de Bont Judith M; van Doorn Jaap; Reddingius Roel E; Graat Gerard H M; Passier Monique M C J; den Boer Monique L; Pieters Rob
Various components of the insulin-like growth factor system in tumor tissue, cerebrospinal fluid and peripheral blood of pediatric medulloblastoma and ependymoma patients.
International journal of cancer. Journal international du cancer 2008;123(3):594-600.
-
2008: le Viseur Christoph; Hotfilder Marc; Bomken Simon; Wilson Kerrie; Röttgers Silja; Schrauder André; Rosemann Annegret; Irving Julie; Stam Ronald W; Shultz Leonard D; Harbott Jochen; Jürgens Heribert; Schrappe Martin; Pieters Rob; Vormoor Josef
In childhood acute lymphoblastic leukemia, blasts at different stages of immunophenotypic maturation have stem cell properties.
Cancer cell 2008;14(1):47-58.
-
2008: de Bont Judith M; Vanderstichele Hugo; Reddingius Roel E; Pieters Rob; van Gool Stefaan W
Increased total-Tau levels in cerebrospinal fluid of pediatric hydrocephalus and brain tumor patients.
European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2008;12(4):334-41.
-
2008: de Vries A C H; Langerak A W; Verhaaf B; Niemeyer C M; Stary J; Schmiegelow K; van Wering E R; Zwaan C M; Beishuizen A; Pieters R; van den Heuvel-Eibrink M M
T-cell receptor Vbeta CDR3 oligoclonality frequently occurs in childhood refractory cytopenia (MDS-RC) and severe aplastic anemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2008;22(6):1170-4.
-
2008: Van Vlierberghe Pieter; van Grotel Martine; Tchinda Joëlle; Lee Charles; Beverloo H Berna; van der Spek Peter J; Stubbs Andrew; Cools Jan; Nagata Kyosuke; Fornerod Maarten; Buijs-Gladdines Jessica; Horstmann Martin; van Wering Elisabeth R; Soulier Jean; Pieters Rob; Meijerink Jules P P
The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia.
Blood 2008;111(9):4668-80.
-
2008: Van Vlierberghe P; Homminga I; Zuurbier L; Gladdines-Buijs J; van Wering E R; Horstmann M; Beverloo H B; Pieters R; Meijerink J P P
Cooperative genetic defects in TLX3 rearranged pediatric T-ALL.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2008;22(4):762-70.
-
2008: Balgobind Brian V; Van Vlierberghe Pieter; van den Ouweland Ans M W; Beverloo H Berna; Terlouw-Kromosoeto Joan N R; van Wering Elisabeth R; Reinhardt Dirk; Horstmann Martin; Kaspers Gertjan J L; Pieters Rob; Zwaan C Michel; Van den Heuvel-Eibrink Marry M; Meijerink Jules P P
Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosis.
Blood 2008;111(8):4322-8.
-
2008: Hartman Annelies; van den Bos Cor; Stijnen Theo; Pieters Rob
Decrease in peripheral muscle strength and ankle dorsiflexion as long-term side effects of treatment for childhood cancer.
Pediatric blood & cancer 2008;50(4):833-7.
-
2008: Pieters Rob; Carroll William L
Biology and treatment of acute lymphoblastic leukemia.
Pediatric clinics of North America 2008;55(1):1-20, ix.
-
2008: van Grotel M; Meijerink J P P; van Wering E R; Langerak A W; Beverloo H B; Buijs-Gladdines J G C A M; Burger N B; Passier M; van Lieshout E M; Kamps W A; Veerman A J P; van Noesel M M; Pieters R
Prognostic significance of molecular-cytogenetic abnormalities in pediatric T-ALL is not explained by immunophenotypic differences.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2008;22(1):124-31.
-
2007: van Beek Robert D; Smit Marij; van den Heuvel-Eibrink Marry M; de Jong Frank H; Hakvoort-Cammel Friederike G; van den Bos Cor; van den Berg Henk; Weber Rob F A; Pieters Rob; de Muinck Keizer-Schrama Sabine M P F
Inhibin B is superior to FSH as a serum marker for spermatogenesis in men treated for Hodgkin's lymphoma with chemotherapy during childhood.
Human reproduction (Oxford, England) 2007;22(12):3215-22.
-
2007: Stam Ronald W; den Boer Monique L; Schneider Pauline; Meier Marrit; Beverloo H Berna; Pieters Rob
D-HPLC analysis of the entire FLT3 gene in MLL rearranged and hyperdiploid acute lymphoblastic leukemia.
Haematologica 2007;92(11):1565-8.
-
2007: de Vries Andrica C H; Stam Ronald W; Schneider Pauline; Niemeyer Charlotte M; van Wering Elisabeth R; Haas Oskar A; Kratz Christian P; den Boer Monique L; Pieters Rob; van den Heuvel-Eibrink Marry M
Role of mutation independent constitutive activation of FLT3 in juvenile myelomonocytic leukemia.
Haematologica 2007;92(11):1557-60.
-
2007: Hartman A; van den Bos C; van Dartel N; Stijnen Th; Pieters R
No adverse effect of vincristine on handwriting in children after completion of therapy.
Pediatric blood & cancer 2007;49(6):841-5.
-
2007: Stam Ronald W; Schneider Pauline; de Lorenzo Paola; Valsecchi Maria G; den Boer Monique L; Pieters Rob
Prognostic significance of high-level FLT3 expression in MLL-rearranged infant acute lymphoblastic leukemia.
Blood 2007;110(7):2774-5.
-
2007: van Beek Robert D; van den Heuvel-Eibrink Marry M; Laven Joop S E; de Jong Frank H; Themmen Axel P N; Hakvoort-Cammel Friederike G; van den Bos Cor; van den Berg Henk; Pieters Rob; de Muinck Keizer-Schrama Sabine M P F
Anti-Mullerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin's lymphoma during childhood.
The Journal of clinical endocrinology and metabolism 2007;92(10):3869-74.
-
2007: O'Neil Jennifer; Grim Jonathan; Strack Peter; Rao Sudhir; Tibbitts Deanne; Winter Christopher; Hardwick James; Welcker Markus; Meijerink Jules P; Pieters Rob; Draetta Giulio; Sears Rosalie; Clurman Bruce E; Look A Thomas
FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors.
The Journal of experimental medicine 2007;204(8):1813-24.
-
2007: de Koning Barbara A; van der Schoor Sophie R; Wattimena Darcos L; de Laat Peter C; Pieters Rob; van Goudoever Johannes B
Chemotherapy does not influence intestinal amino acid uptake in children.
Pediatric research 2007;62(2):195-9.
-
2007: de Koning Barbara A E; Lindenbergh-Kortleve Dicky J; Pieters Rob; Büller Hans A; Renes Ingrid B; Einerhand Alexandra W C
Alterations in epithelial and mesenchymal intestinal gene expression during doxorubicin-induced mucositis in mice.
Digestive diseases and sciences 2007;52(8):1814-25.
-
2007: Pieters Rob; Schrappe Martin; De Lorenzo Paola; Hann Ian; De Rossi Giulio; Felice Maria; Hovi Liisa; LeBlanc Thierry; Szczepanski Tomasz; Ferster Alice; Janka Gritta; Rubnitz Jeffrey; Silverman Lewis; Stary Jan; Campbell Myriam; Li Chi-Kong; Mann Georg; Suppiah Ram; Biondi Andrea; Vora Ajay; Valsecchi Maria Grazia
A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial.
Lancet 2007;370(9583):240-50.
-
2007: den Boer Monique L; Pieters Rob
Microarray-based identification of new targets for specific therapies in pediatric leukemia.
Current drug targets 2007;8(6):761-4.
-
2007: de Bont Judith M; den Boer Monique L; Kros Johan M; Passier Monique M C J; Reddingius Roel E; Smitt Peter A E Sillevis; Luider Theo M; Pieters Rob
Identification of novel biomarkers in pediatric primitive neuroectodermal tumors and ependymomas by proteome-wide analysis.
Journal of neuropathology and experimental neurology 2007;66(6):505-16.
-
2007: Lahortiga Idoya; De Keersmaecker Kim; Van Vlierberghe Pieter; Graux Carlos; Cauwelier Barbara; Lambert Frederic; Mentens Nicole; Beverloo H Berna; Pieters Rob; Speleman Frank; Odero Maria D; Bauters Marijke; Froyen Guy; Marynen Peter; Vandenberghe Peter; Wlodarska Iwona; Meijerink Jules P P; Cools Jan
Duplication of the MYB oncogene in T cell acute lymphoblastic leukemia.
Nature genetics 2007;39(5):593-5.
-
2007: Tissing Wim J E; den Boer Monique L; Meijerink Jules P P; Menezes Renee X; Swagemakers Sigrid; van der Spek Peter J; Sallan Stephen E; Armstrong Scott A; Pieters Rob
Genomewide identification of prednisolone-responsive genes in acute lymphoblastic leukemia cells.
Blood 2007;109(9):3929-35.
-
2007: Maas M H; Cransberg K; van Grotel M; Pieters R; van den Heuvel-Eibrink M M
Renin-induced hypertension in Wilms tumor patients.
Pediatric blood & cancer 2007;48(5):500-3.
-
2007: de Koning Barbara A E; Philipsen-Geerling Bertine; Hoijer Maarten; Hählen Karel; Büller Hans A; Pieters Rob
Protection against chemotherapy induced mucositis by TGF-beta(2) in childhood cancer patients: results from a randomized cross-over study.
Pediatric blood & cancer 2007;48(5):532-9.
-
2007: Jansen M W J C; Corral L; van der Velden V H J; Panzer-Grümayer R; Schrappe M; Schrauder A; Marschalek R; Meyer C; den Boer M L; Hop W J C; Valsecchi M G; Basso G; Biondi A; Pieters R; van Dongen J J M
Immunobiological diversity in infant acute lymphoblastic leukemia is related to the occurrence and type of MLL gene rearrangement.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007;21(4):633-41.
-
2007: Huang L; Lequin M; Pieters R; van den Heuvel-Eibrink M M
The clinical value of follow-up examinations in childhood T-cell acute lymphoblastic leukemia and T-cell non-Hodgkin's lymphoma.
Pediatric blood & cancer 2007;48(4):468-72.
-
2007: de Koning Barbara A E; Sluis Maria van der; Lindenbergh-Kortleve Dicky J; Velcich Anna; Pieters Rob; Büller Hans A; Einerhand Alexandra W C; Renes Ingrid B
Methotrexate-induced mucositis in mucin 2-deficient mice.
Journal of cellular physiology 2007;210(1):144-52.
-
2006: Van Vlierberghe Pieter; van Grotel Martine; Beverloo H Berna; Lee Charles; Helgason Tryggvi; Buijs-Gladdines Jessica; Passier Monique; van Wering Elisabeth R; Veerman Anjo J P; Kamps Willem A; Meijerink Jules P P; Pieters Rob
The cryptic chromosomal deletion del(11)(p12p13) as a new activation mechanism of LMO2 in pediatric T-cell acute lymphoblastic leukemia.
Blood 2006;108(10):3520-9.
-
2006: Wei Guo; Twomey David; Lamb Justin; Schlis Krysta; Agarwal Jyoti; Stam Ronald W; Opferman Joseph T; Sallan Stephen E; den Boer Monique L; Pieters Rob; Golub Todd R; Armstrong Scott A
Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance.
Cancer cell 2006;10(4):331-42.
-
2006: van Grotel Martine; Meijerink Jules P P; Beverloo H Berna; Langerak Anton W; Buys-Gladdines Jessica G C A M; Schneider Pauline; Poulsen Tim S; den Boer Monique L; Horstmann Martin; Kamps Willem A; Veerman Anjo J P; van Wering Elisabeth R; van Noesel Max M; Pieters Rob
The outcome of molecular-cytogenetic subgroups in pediatric T-cell acute lymphoblastic leukemia: a retrospective study of patients treated according to DCOG or COALL protocols.
Haematologica 2006;91(9):1212-21.
-
2006: Holleman Amy; den Boer Monique L; Cheok Meyling H; Kazemier Karin M; Pei Deqing; Downing James R; Janka-Schaub Gritta E; Göbel Ulrich; Graubner Ulrike B; Pui Ching-Hon; Evans William E; Pieters Rob
Expression of the outcome predictor in acute leukemia 1 (OPAL1) gene is not an independent prognostic factor in patients treated according to COALL or St Jude protocols.
Blood 2006;108(6):1984-90.
-
2006: van Grotel Martine; Lam King H; de Man Rogier; Beishuizen Auke; Pieters Rob; van den Heuvel-Eibrink Marry M
High relapse rate in children with non-advanced nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL or nodular paragranuloma) treated with chemotherapy only.
Leukemia & lymphoma 2006;47(8):1504-10.
-
2006: Meier M; den Boer M L; Meijerink J P P; Broekhuis M J C; Passier M M C J; van Wering E R; Janka-Schaub G E; Pieters R
Differential expression of p73 isoforms in relation to drug resistance in childhood T-lineage acute lymphoblastic leukaemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(8):1377-84.
-
2006: de Bont Judith M; den Boer Monique L; Reddingius Roel E; Jansen Jaap; Passier Monique; van Schaik Ron H N; Kros Johan M; Sillevis Smitt Peter A E; Luider Theo H; Pieters Rob
Identification of apolipoprotein A-II in cerebrospinal fluid of pediatric brain tumor patients by protein expression profiling.
Clinical chemistry 2006;52(8):1501-9.
-
2006: von Bergh Anne R M; van Drunen Ellen; van Wering Elisabeth R; van Zutven Laura J C M; Hainmann Ina; Lönnerholm Gudmar; Meijerink Jules P; Pieters Rob; Beverloo H Berna
High incidence of t(7;12)(q36;p13) in infant AML but not in infant ALL, with a dismal outcome and ectopic expression of HLXB9.
Genes, chromosomes & cancer 2006;45(8):731-9.
-
2006: Tissing Wim J E; Meijerink Jules P P; Brinkhof Bas; Broekhuis Mathilde J C; Menezes Renee X; den Boer Monique L; Pieters Rob
Glucocorticoid-induced glucocorticoid-receptor expression and promoter usage is not linked to glucocorticoid resistance in childhood ALL.
Blood 2006;108(3):1045-9.
-
2006: van Vlierberghe P; Meijerink J P P; Lee C; Ferrando A A; Look A T; van Wering E R; Beverloo H B; Aster J C; Pieters R
A new recurrent 9q34 duplication in pediatric T-cell acute lymphoblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(7):1245-53.
-
2006: Hooijberg J H; de Vries N A; Kaspers G J L; Pieters R; Jansen G; Peters G J
Multidrug resistance proteins and folate supplementation: therapeutic implications for antifolates and other classes of drugs in cancer treatment.
Cancer chemotherapy and pharmacology 2006;58(1):1-12.
-
2006: Zwaan Christian Michel; den Boer Monique L; Kazemier Karin M; Hählen Karel; Loonen Anne H; Reinhardt Dirk; Creutzig Ursula; Kaspers Gertjan J L; Pieters Rob
Does modulation of P-glycoprotein have clinical relevance in pediatric acute myeloid leukemia?
Blood 2006;107(12):4975-6; author reply 4976-7.
-
2006: de Koning Barbara A E; van Dieren Jolanda M; Lindenbergh-Kortleve Dicky J; van der Sluis Maria; Matsumoto Tetsuya; Yamaguchi Keizo; Einerhand Alexandra W; Samsom Janneke N; Pieters Rob; Nieuwenhuis Edward E S
Contributions of mucosal immune cells to methotrexate-induced mucositis.
International immunology 2006;18(6):941-9.
-
2006: Appel Inge M; den Boer Monique L; Meijerink Jules P P; Veerman Anjo J P; Reniers Nathalie C M; Pieters Rob
Up-regulation of asparagine synthetase expression is not linked to the clinical response L-asparaginase in pediatric acute lymphoblastic leukemia.
Blood 2006;107(11):4244-9.
-
2006: de Koning Barbara A E; Lindenbergh-Kortleve Dicky J; Pieters Rob; Rings Edmond H H M; Büller Hans A; Renes Ingrid B; Einerhand Alexandra W C
The effect of cytostatic drug treatment on intestine-specific transcription factors Cdx2, GATA-4 and HNF-1alpha in mice.
Cancer chemotherapy and pharmacology 2006;57(6):801-10.
-
2006: van der Velden Vincent H J; Hoogeveen Patricia G; Pieters Rob; van Dongen Jacques J M
Impact of two independent bone marrow samples on minimal residual disease monitoring in childhood acute lymphoblastic leukaemia.
British journal of haematology 2006;133(4):382-8.
-
2006: Neudenberger J; Hotfilder M; Rosemann A; Langebrake C; Reinhardt D; Pieters R; Schrauder A; Schrappe M; Röttgers S; Harbott J; Vormoor J
Lack of expression of the chondroitin sulphate proteoglycan neuron-glial antigen 2 on candidate stem cell populations in paediatric acute myeloid leukaemia/abn(11q23) and acute lymphoblastic leukaemia/t(4;11).
British journal of haematology 2006;133(3):337-44.
-
2006: van Beek R D; Bezemer D D L; Meijerink J P P; de Muinck Keizer-Schrama S M P F; Haas O A; Te Winkel L; Pieters R; van den Heuvel-Eibrink M
Repeats in the kringle IV encoding domains in the Apo(a) gene and serum lipoprotein(a) level do not contribute to the risk for avascular necrosis of the bone (AVN) in pediatric acute lymphoblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(5):879-80.
-
2006: Appel Inge M; Hop Wim C J; Pieters Rob
Changes in hypercoagulability by asparaginase: a randomized study between two asparaginases.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2006;17(2):139-46.
-
2006: Hartman Annelies; van den Bos Cor; Stijnen Theo; Pieters Rob
Decrease in motor performance in children with cancer is independent of the cumulative dose of vincristine.
Cancer 2006;106(6):1395-401.
-
2006: Stam Ronald W; den Boer Monique L; Pieters Rob
Towards targeted therapy for infant acute lymphoblastic leukaemia.
British journal of haematology 2006;132(5):539-51.
-
2006: Stams W A G; Beverloo H B; den Boer M L; de Menezes R X; Stigter R L; van Drunen E; Ramakers-van-Woerden N L; Loonen A H; van Wering E R; Janka-Schaub G E; Pieters R
Incidence of additional genetic changes in the TEL and AML1 genes in DCOG and COALL-treated t(12;21)-positive pediatric ALL, and their relation with drug sensitivity and clinical outcome.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(3):410-6.
-
2006: Stam R W; den Boer M L; Passier M M C J; Janka-Schaub G E; Sallan S E; Armstrong S A; Pieters R
Silencing of the tumor suppressor gene FHIT is highly characteristic for MLL gene rearranged infant acute lymphoblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(2):264-71.
-
2006: Hubeek Isabelle; Peters Godefridus J; Broekhuizen Richard; Zwaan Christian M; Kaaijk Patricia; van Wering Elisabeth S; Gibson Brenda E S; Creutzig Ursula; Janka-Schaub Gritta E; den Boer Monique L; Pieters Rob; Kaspers Gertjan J L
In vitro sensitivity and cross-resistance to deoxynucleoside analogs in childhood acute leukemia.
Haematologica 2006;91(1):17-23.
-
2006: Stam R W; Hubeek I; den Boer M L; Buijs-Gladdines J G C A M; Creutzig U; Kaspers G J L; Pieters R
MLL gene rearrangements have no direct impact on Ara-C sensitivity in infant acute lymphoblastic leukemia and childhood M4/M5 acute myeloid leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(1):179-82.
-
2006: Holleman Amy; den Boer Monique L; de Menezes Renée X; Cheok Meyling H; Cheng Cheng; Kazemier Karin M; Janka-Schaub Gritta E; Göbel Ulrich; Graubner Ulrike B; Evans William E; Pieters Rob
The expression of 70 apoptosis genes in relation to lineage, genetic subtype, cellular drug resistance, and outcome in childhood acute lymphoblastic leukemia.
Blood 2006;107(2):769-76.
-
2006: van Beek Robert D; de Muinck Keizer-Schrama Sabine M P F; Hakvoort-Cammel Friederike G; van der Sluis Inge M; Krenning Eric P; Pieters Rob; van den Heuvel-Eibrink Marry M
No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemia.
Pediatric blood & cancer 2006;46(1):88-93.
-
2005: Hubeek I; Stam R W; Peters G J; Broekhuizen R; Meijerink J P P; van Wering E R; Gibson B E S; Creutzig U; Zwaan C M; Cloos J; Kuik D J; Pieters R; Kaspers G J L
The human equilibrative nucleoside transporter 1 mediates in vitro cytarabine sensitivity in childhood acute myeloid leukaemia.
British journal of cancer 2005;93(12):1388-94.
-
2005: Stams Wendy A G; den Boer Monique L; Beverloo H Berna; Kazemier Karin M; van Wering Elisabeth R; Janka-Schaub Gritta E; Pieters Rob
Effect of the histone deacetylase inhibitor depsipeptide on B-cell differentiation in both TEL-AML1-positive and negative childhood acute lymphoblastic leukemia.
Haematologica 2005;90(12):1697-9.
-
2005: Van Vlierberghe Pieter; Meijerink Jules P P; Stam Ronald W; van der Smissen Wendy; van Wering Elisabeth R; Beverloo H Berna; Pieters Rob
Activating FLT3 mutations in CD4+/CD8- pediatric T-cell acute lymphoblastic leukemias.
Blood 2005;106(13):4414-5.
-
2005: Meier M; den Boer M L; Hall A G; Irving J A E; Passier M; Minto L; van Wering E R; Janka-Schaub G E; Pieters R
Relation between genetic variants of the ataxia telangiectasia-mutated (ATM) gene, drug resistance, clinical outcome and predisposition to childhood T-lineage acute lymphoblastic leukaemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(11):1887-95.
-
2005: Stam Ronald W; den Boer Monique L; Schneider Pauline; Nollau Peter; Horstmann Martin; Beverloo H Berna; van der Voort Ella; Valsecchi Maria G; de Lorenzo Paola; Sallan Stephen E; Armstrong Scott A; Pieters Rob
Targeting FLT3 in primary MLL-gene-rearranged infant acute lymphoblastic leukemia.
Blood 2005;106(7):2484-90.
-
2005: Tissing Wim J E; Lauten Melchior; Meijerink Jules P P; den Boer Monique L; Koper Jan Willem; Sonneveld Peter; Pieters Rob
Expression of the glucocorticoid receptor and its isoforms in relation to glucocorticoid resistance in childhood acute lymphocytic leukemia.
Haematologica 2005;90(9):1279-81.
-
2005: Vrakking Astrid M; van der Heide Agnes; Arts Willem Frans M; Pieters Rob; van der Voort Edwin; Rietjens Judith A C; Onwuteaka-Philipsen Bregje D; van der Maas Paul J; van der Wal Gerrit
Medical end-of-life decisions for children in the Netherlands.
Archives of pediatrics & adolescent medicine 2005;159(9):802-9.
-
2005: Buitendijk Saskia; van de Ven Cees P; Dumans Ton G; den Hollander Jan C; Nowak Peter J; Tissing Wim J; Pieters Rob; van den Heuvel-Eibrink Marry M
Pediatric aggressive fibromatosis: a retrospective analysis of 13 patients and review of literature.
Cancer 2005;104(5):1090-9.
-
2005: Holleman Amy; den Boer Monique L; Kazemier Karin M; Beverloo H Berna; von Bergh Anne R M; Janka-Schaub Gritta E; Pieters Rob
Decreased PARP and procaspase-2 protein levels are associated with cellular drug resistance in childhood acute lymphoblastic leukemia.
Blood 2005;106(5):1817-23.
-
2005: Tissing Wim J E; Meijerink Jules P P; den Boer Monique L; Brinkhof Bas; van Rossum Elisabeth F C; van Wering Elisabeth R; Koper Jan W; Sonneveld Pieter; Pieters Rob
Genetic variations in the glucocorticoid receptor gene are not related to glucocorticoid resistance in childhood acute lymphoblastic leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(16):6050-6.
-
2005: van Zutven L J C M; van Drunen E; de Bont J M; Wattel M M; Den Boer M L; Pieters R; Hagemeijer A; Slater R M; Beverloo H B
CDKN2 deletions have no prognostic value in childhood precursor-B acute lymphoblastic leukaemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(7):1281-4.
-
2005: de Jonge Robert; Hooijberg Jan Hendrik; van Zelst Bertrand D; Jansen Gerrit; van Zantwijk Christina H; Kaspers Gertjan J L; Peters Godefridus J; Ravindranath Yaddanapudi; Pieters Rob; Lindemans Jan
Effect of polymorphisms in folate-related genes on in vitro methotrexate sensitivity in pediatric acute lymphoblastic leukemia.
Blood 2005;106(2):717-20.
-
2005: Kaspers Gertjan J L; Wijnands Jelle J M; Hartmann Reinhard; Huismans Loekie; Loonen Anne H; Stackelberg Arend; Henze Guenter; Pieters Robrecht; Hählen Karel; Van Wering Elisabeth R; Veerman Anjo J P
Immunophenotypic cell lineage and in vitro cellular drug resistance in childhood relapsed acute lymphoblastic leukaemia.
European journal of cancer (Oxford, England : 1990) 2005;41(9):1300-3.
-
2005: Stams Wendy A G; den Boer Monique L; Holleman Amy; Appel Inge M; Beverloo H Berna; van Wering Elisabeth R; Janka-Schaub Gritta E; Evans William E; Pieters Rob
Asparagine synthetase expression is linked with L-asparaginase resistance in TEL-AML1-negative but not TEL-AML1-positive pediatric acute lymphoblastic leukemia.
Blood 2005;105(11):4223-5.
-
2005: Tissing W J E; Meijerink J P P; den Boer M L; Brinkhof B; Pieters R
mRNA expression levels of (co)chaperone molecules of the glucocorticoid receptor are not involved in glucocorticoid resistance in pediatric ALL.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(5):727-33.
-
2005: Meijerink Jules P P; Van Lieshout Esther M M; Beverloo H Berna; Van Drunen Ellen; Mensink Ewald J B M; Macville Merryn; Pieters Rob
Novel murine B-cell lymphoma/leukemia model to study BCL2-driven oncogenesis.
International journal of cancer. Journal international du cancer 2005;114(6):917-25.
-
2005: Stams Wendy A G; den Boer Monique L; Beverloo H Berna; Meijerink Jules P P; van Wering Elisabeth R; Janka-Schaub Gritta E; Pieters Rob
Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(8):2974-80.
-
2005: Lugthart Sanne; Cheok Meyling H; den Boer Monique L; Yang Wenjian; Holleman Amy; Cheng Cheng; Pui Ching-Hon; Relling Mary V; Janka-Schaub Gritta E; Pieters Rob; Evans William E
Identification of genes associated with chemotherapy crossresistance and treatment response in childhood acute lymphoblastic leukemia.
Cancer cell 2005;7(4):375-86.
-
2005: de Bont J M; van der Holt B; Dekker A W; van der Does-van den Berg A; Sonneveld P; Pieters R
[Adolescents with acute lymphatic leukaemia achieve significantly better results when treated following Dutch paediatric oncology protocols than with adult protocols]
Nederlands tijdschrift voor geneeskunde 2005;149(8):400-6.
-
2005: Hotfilder Marc; Röttgers Silja; Rosemann Annegret; Schrauder André; Schrappe Martin; Pieters Rob; Jürgens Heribert; Harbott Jochen; Vormoor Josef
Leukemic stem cells in childhood high-risk ALL/t(9;22) and t(4;11) are present in primitive lymphoid-restricted CD34+CD19- cells.
Cancer research 2005;65(4):1442-9.
-
2005: Stams W A G; den Boer M L; Beverloo H B; van Wering E R; Pieters R
Upregulation of asparagine synthetase and cell cycle arrest in t(12;21)-positive ALL.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(2):318-9; author reply 319-21.
-
2005: Meyer Claus; Schneider Bjoern; Reichel Martin; Angermueller Sieglinde; Strehl Sabine; Schnittger Susanne; Schoch Claudia; Jansen Mieke W J C; van Dongen Jacques J; Pieters Rob; Haas Oskar A; Dingermann Theo; Klingebiel Thomas; Marschalek Rolf
Diagnostic tool for the identification of MLL rearrangements including unknown partner genes.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(2):449-54.
-
2005: Top P C; Tissing W J E; Kuiper J W; Pieters R; van Eijck C H J
L-asparaginase-induced severe necrotizing pancreatitis successfully treated with percutaneous drainage.
Pediatric blood & cancer 2005;44(1):95-7.
-
2004: de Bont J M; Holt B van der; Dekker A W; van der Does-van den Berg A; Sonneveld P; Pieters R
Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric vs adult protocols in the Netherlands.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(12):2032-5.
-
2004: Hooijberg J H; Peters G J; Kaspers G J L; Wielinga P R; Veerman A J P; Pieters R; Jansen G
Online fluorescent method to assess BCRP/ABCG2 activity in suspension cells.
Nucleosides, nucleotides & nucleic acids 2004;23(8-9):1451-4.
-
2004: de Bont J M; Pieters R
Management of hyperuricemia with rasburicase review.
Nucleosides, nucleotides & nucleic acids 2004;23(8-9):1431-40.
-
2004: Neels N J J; Tissing W J E; Pieters R; Oosterhuis J W; van de Ven C P; Devos A S
Treatment of an infant with a vaginal yolk sac tumour and distant metastases with chemotherapy only.
Pediatric blood & cancer 2004;43(3):296-7.
-
2004: Holleman Amy; Cheok Meyling H; den Boer Monique L; Yang Wenjian; Veerman Anjo J P; Kazemier Karin M; Pei Deqing; Cheng Cheng; Pui Ching-Hon; Relling Mary V; Janka-Schaub Gritta E; Pieters Rob; Evans William E
Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment.
The New England journal of medicine 2004;351(6):533-42.
-
2004: Hooijberg Jan Hendrik; Jansen Gerrit; Assaraf Yehuda G; Kathmann Ietje; Pieters Rob; Laan Adrie C; Veerman Anjo J P; Kaspers Gertjan J L; Peters Godefridus J
Folate concentration dependent transport activity of the Multidrug Resistance Protein 1 (ABCC1).
Biochemical pharmacology 2004;67(8):1541-8.
-
2004: Haarman E G; Kaspers G J L; Pieters R; Rottier M M A; Veerman A J P
Glucocorticoid receptor alpha, beta and gamma expression vs in vitro glucocorticod resistance in childhood leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(3):530-7.
-
2004: Ramakers-van Woerden N L; Beverloo H B; Veerman A J P; Camitta B M; Loonen A H; van Wering E R; Slater R M; Harbott J; den Boer M L; Ludwig W D; Haas O A; Janka-Schaub G E; Pieters R
In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(3):521-9.
-
2004: Stam R W; van den Heuvel-Eibrink M M; den Boer M L; Ebus M E G; Janka-Schaub G E; Allen J D; Pieters R
Multidrug resistance genes in infant acute lymphoblastic leukemia: Ara-C is not a substrate for the breast cancer resistance protein.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(1):78-83.
-
2003: Sonneveld Pieter; Pieters Rob
Immunophenotyping as a guide for targeted therapy.
Best practice & research. Clinical haematology 2003;16(4):629-44.
-
2003: Holleman Amy; den Boer Monique L; Kazemier Karin M; Janka-Schaub Gritta E; Pieters Rob
Resistance to different classes of drugs is associated with impaired apoptosis in childhood acute lymphoblastic leukemia.
Blood 2003;102(13):4541-6.
-
2003: Appel I M; Pinheiro J P V; den Boer M L; Lanvers C; Reniers N C M; Boos J; Pieters R
Lack of asparagine depletion in the cerebrospinal fluid after one intravenous dose of PEG-asparaginase: a window study at initial diagnosis of childhood ALL.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2003;17(11):2254-6.
-
2003: van Noesel Max M; van Bezouw Saskia; Voûte P A; Herman James G; Pieters Rob; Versteeg Rogier
Clustering of hypermethylated genes in neuroblastoma.
Genes, chromosomes & cancer 2003;38(3):226-33.
-
2003: Zwaan Christian M; Meshinchi Soheil; Radich Jerald P; Veerman Anjo J P; Huismans Dieuwke R; Munske Leonhard; Podleschny Martina; Hählen Karel; Pieters Rob; Zimmermann Martin; Reinhardt Dirk; Harbott Jochen; Creutzig Ursula; Kaspers Gertjan J L; Griesinger Frank
FLT3 internal tandem duplication in 234 children with acute myeloid leukemia: prognostic significance and relation to cellular drug resistance.
Blood 2003;102(7):2387-94.
-
2003: Den Boer M L; Harms D O; Pieters R; Kazemier K M; Gobel U; Körholz D; Graubner U; Haas R J; Jorch N; Spaar H J; Kaspers G J L; Kamps W A; Van der Does-Van den Berg A; Van Wering E R; Veerman A J P; Janka-Schaub G E
Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(17):3262-8.
-
2003: Zheng Ping-Pin; Luider Theo M; Pieters Rob; Avezaat Cees J J; van den Bent Martin J; Sillevis Smitt Peter A E; Kros Johan M
Identification of tumor-related proteins by proteomic analysis of cerebrospinal fluid from patients with primary brain tumors.
Journal of neuropathology and experimental neurology 2003;62(8):855-62.
-
2003: van Noesel Max M; Pieters Rob; Voûte P A; Versteeg Rogier
The N-myc paradox: N-myc overexpression in neuroblastomas is associated with sensitivity as well as resistance to apoptosis.
Cancer letters 2003;197(1-2):165-72.
-
2003: Stams Wendy A G; den Boer Monique L; Beverloo H Berna; Meijerink Jules P P; Stigter Rolinda L; van Wering Elisabeth R; Janka-Schaub Gritta E; Slater Rosalyn; Pieters Rob
Sensitivity to L-asparaginase is not associated with expression levels of asparagine synthetase in t(12;21)+ pediatric ALL.
Blood 2003;101(7):2743-7.
-
2003: Armstrong Scott A; Kung Andrew L; Mabon Meghann E; Silverman Lewis B; Stam Ronald W; Den Boer Monique L; Pieters Rob; Kersey John H; Sallan Stephen E; Fletcher Jonathan A; Golub Todd R; Griffin James D; Korsmeyer Stanley J
Inhibition of FLT3 in MLL. Validation of a therapeutic target identified by gene expression based classification.
Cancer cell 2003;3(2):173-83.
-
2003: Stam Ronald W; den Boer Monique L; Meijerink Jules P P; Ebus Marli E G; Peters Godefridus J; Noordhuis Paul; Janka-Schaub Gritta E; Armstrong Scott A; Korsmeyer Stanley J; Pieters Rob
Differential mRNA expression of Ara-C-metabolizing enzymes explains Ara-C sensitivity in MLL gene-rearranged infant acute lymphoblastic leukemia.
Blood 2003;101(4):1270-6.
-
2003: Tissing W J E; Meijerink J P P; den Boer M L; Pieters R
Molecular determinants of glucocorticoid sensitivity and resistance in acute lymphoblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2003;17(1):17-25.
-
2003: Kearns Pamela R; Chrzanowska-Lightowlers Zofia M A; Pieters Rob; Veerman Anjo; Hall Andrew G
Mu class glutathione S-transferase mRNA isoform expression in acute lymphoblastic leukaemia.
British journal of haematology 2003;120(1):80-8.
-
2002: Zwaan Christian M; Kaspers Gertjan J L; Pieters Rob; Hählen Karel; Huismans Dieuwke R; Zimmermann Martin; Harbott Jochen; Slater Rosalyn M; Creutzig Ursala; Veerman Anjo J P
Cellular drug resistance in childhood acute myeloid leukemia is related to chromosomal abnormalities.
Blood 2002;100(9):3352-60.
-
2002: Haarman E G; Kaspers G J L; Pieters R; Rottier M M A; Den Boer M L; Janka-Schaub G E; Veerman A J P
In vitro glucocorticoid resistance in childhood leukemia correlates with receptor affinity determined at 37 degrees C, but not with affinity determined at room temperature.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2002;16(9):1882-4.
-
2002: Ramakers-van Woerden N L; Pieters R; Hoelzer D; Slater R M; den Boer M L; Loonen A H; Harbott J; Janka-Schaub G E; Ludwig W-D; Ossenkoppele G J; van Wering E R; Veerman A J P;
In vitro drug resistance profile of Philadelphia positive acute lymphoblastic leukemia is heterogeneous and related to age: a report of the Dutch and German Leukemia Study Groups.
Medical and pediatric oncology 2002;38(6):379-86.
-
2002: Ramakers-van Woerden N L; Pieters R; Rots M G; van Zantwijk C H; Noordhuis P; Beverloo H B; Peters G J; van Wering E R; Camitta B M; Pui C-H; Relling M V; Evans W E; Veerman A J P
Infants with acute lymphoblastic leukemia: no evidence for high methotrexate resistance.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2002;16(5):949-51.
-
2002: van den Heuvel-Eibrink M M; Wiemer E A C; Prins A; Meijerink J P P; Vossebeld P J M; van der Holt B; Pieters R; Sonneveld P
Increased expression of the breast cancer resistance protein (BCRP) in relapsed or refractory acute myeloid leukemia (AML).
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2002;16(5):833-9.
-
2002: van Noesel Max M; van Bezouw Saskia; Salomons Gajja S; Voûte P A; Pieters Rob; Baylin Steve B; Herman James G; Versteeg Rogier
Tumor-specific down-regulation of the tumor necrosis factor-related apoptosis-inducing ligand decoy receptors DcR1 and DcR2 is associated with dense promoter hypermethylation.
Cancer research 2002;62(7):2157-61.
-
2002: Zwaan Christian M; Kaspers Gertjan J L; Pieters Rob; Hählen Karel; Janka-Schaub Gritta E; van Zantwijk Christina H; Huismans Dieuwke R; de Vries Esther; Rots Marianne G; Peters Godefridus J; Jansen Gerrit; Creutzig Ursula; Veerman Anjo J P
Different drug sensitivity profiles of acute myeloid and lymphoblastic leukemia and normal peripheral blood mononuclear cells in children with and without Down syndrome.
Blood 2002;99(1):245-51.
-
2002: Armstrong Scott A; Staunton Jane E; Silverman Lewis B; Pieters Rob; den Boer Monique L; Minden Mark D; Sallan Stephen E; Lander Eric S; Golub Todd R; Korsmeyer Stanley J
MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia.
Nature genetics 2002;30(1):41-7.
-
2001: Schmiegelow K; Nyvold C; Seyfarth J; Pieters R; Rottier M M; Knabe N; Ryder L P; Madsen H O; Svejgaard A; Kaspers G J
Post-induction residual leukemia in childhood acute lymphoblastic leukemia quantified by PCR correlates with in vitro prednisolone resistance.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2001;15(7):1066-71.
-
2001: van den Heuvel-Eibrink M M; Wiemer E A; de Boevere M J; van der Holt B; Vossebeld P J; Pieters R; Sonneveld P
MDR1 gene-related clonal selection and P-glycoprotein function and expression in relapsed or refractory acute myeloid leukemia.
Blood 2001;97(11):3605-11.
-
2001: Hubeek I; Ramakers-van Woerden N L; Pieters R; Slater R; Beverloo H B; van Wering E R; Kamps W; Hählen K; Veerman A J
TEL/AML1 fusion is not a prognostic factor in Dutch childhood acute lymphoblastic leukaemia.
British journal of haematology 2001;113(1):254-5.
-
2001: Rots M G; Pieters R; Jansen G; Kaspers G J; Van Zantwijk C H; Noordhuis P; Voorn D A; Van Wering E R; Creutzig U; Veerman A J; Peters G J
A possible role for methotrexate in the treatment of childhood acute myeloid leukaemia, in particular for acute monocytic leukaemia.
European journal of cancer (Oxford, England : 1990) 2001;37(4):492-8.
-
2001: Ramakers-van Woerden N L; Pieters R; Slater R M; Loonen A H; Beverloo H B; van Drunen E; Heyman M; Moreno T C; Rots M G; van Wering E R; Kamps W A; Janka-Schaub G E; Veerman A J
In vitro drug resistance and prognostic impact of p16INK4A/P15INK4B deletions in childhood T-cell acute lymphoblastic leukaemia.
British journal of haematology 2001;112(3):680-90.
-
2001: van den Heuvel-Eibrink M M; Wiemer E A; de Boevere M J; Slater R M; Smit E M; van Noesel M M; van der Holt B; Schoester M; Pieters R; Sonneveld P
MDR1 expression in poor-risk acute myeloid leukemia with partial or complete monosomy 7.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2001;15(3):398-405.
-
2001: Kearns P R; Pieters R; Rottier M M; Pearson A D; Hall A G
Raised blast glutathione levels are associated with an increased risk of relapse in childhood acute lymphocytic leukemia.
Blood 2001;97(2):393-8.
-
2000: Rots M G; Willey J C; Jansen G; Van Zantwijk C H; Noordhuis P; DeMuth J P; Kuiper E; Veerman A J; Pieters R; Peters G J
mRNA expression levels of methotrexate resistance-related proteins in childhood leukemia as determined by a standardized competitive template-based RT-PCR method.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2000;14(12):2166-75.
-
2000: Zwaan C M; Kaspers G J; Pieters R; Ramakers-Van Woerden N L; den Boer M L; Wünsche R; Rottier M M; Hählen K; van Wering E R; Janka-Schaub G E; Creutzig U; Veerman A J
Cellular drug resistance profiles in childhood acute myeloid leukemia: differences between FAB types and comparison with acute lymphoblastic leukemia.
Blood 2000;96(8):2879-86.
-
2000: Styczynski J; Pieters R; Huismans D R; Schuurhuis G J; Wysocki M; Veerman A J
In vitro drug resistance profiles of adult versus childhood acute lymphoblastic leukaemia.
British journal of haematology 2000;110(4):813-8.
-
2000: Rots M G; Pieters R; Kaspers G J; Veerman A J; Peters G J; Jansen G
Classification of ex vivo methotrexate resistance in acute lymphoblastic and myeloid leukaemia.
British journal of haematology 2000;110(4):791-800.
-
2000: Ramakers-van Woerden N L; Pieters R; Loonen A H; Hubeek I; van Drunen E; Beverloo H B; Slater R M; Harbott J; Seyfarth J; van Wering E R; Hählen K; Schmiegelow K; Janka-Schaub G E; Veerman A J
TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia.
Blood 2000;96(3):1094-9.
-
2000: Rots M G; Pieters R; Peters G J; Noordhuis P; Van Zantwijk C H; Henze G; Janka-Schaub G E; Veerman A J; Jansen G
Methotrexate resistance in relapsed childhood acute lymphoblastic leukaemia.
British journal of haematology 2000;109(3):629-34.
-
2000: Dübbers A; Würthwein G; Müller H J; Schulze-Westhoff P; Winkelhorst M; Kurzknabe E; Lanvers C; Pieters R; Kaspers G J; Creutzig U; Ritter J; Boos J
Asparagine synthetase activity in paediatric acute leukaemias: AML-M5 subtype shows lowest activity.
British journal of haematology 2000;109(2):427-9.
-
2000: van den Heuvel-Eibrink M M; Sonneveld P; Pieters R
The prognostic significance of membrane transport-associated multidrug resistance (MDR) proteins in leukemia.
International journal of clinical pharmacology and therapeutics 2000;38(3):94-110.
-
1999: Den Boer M L; Pieters R; Kazemier K M; Janka-Schaub G E; Henze G; Veerman A J
Relationship between the intracellular daunorubicin concentration, expression of major vault protein/lung resistance protein and resistance to anthracyclines in childhood acute lymphoblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1999;13(12):2023-30.
-
1999: Rots M G; Pieters R; Peters G J; van Zantwijk C H; Mauritz R; Noordhuis P; Willey J C; Hählen K; Creutzig U; Janka-Schaub G; Kaspers G J; Veerman A J; Jansen G
Circumvention of methotrexate resistance in childhood leukemia subtypes by rationally designed antifolates.
Blood 1999;94(9):3121-8.
-
1999: Mui D; Pieters R; Veerman A J
[Blood platelets in children too few and too large: the giant platelet syndromes]
Nederlands tijdschrift voor geneeskunde 1999;143(38):1918-22.
-
1999: Kaspers G J; Zwaan C M; Veerman A J; Rots M G; Pieters R; Bucsky P; Domula M; Göbel U; Graf N; Havers W; Jorch N; Kabisch K; Spaar H J; Ritter J; Creutzig U
Cellular drug resistance in acute myeloid leukemia: literature review and preliminary analysis of an ongoing collaborative study.
Klinische Pädiatrie 1999;211(4):239-44.
-
1999: Den Boer M L; Kapaun P; Pieters R; Kazemier K M; Janka-Schaub G E; Veerman A J
Myeloid antigen co-expression in childhood acute lymphoblastic leukaemia: relationship with in vitro drug resistance.
British journal of haematology 1999;105(4):876-82.
-
1999: Duyn A E; Kaspers G J; Pieters R; Van Zantwijk C H; Broekema G J; Hählen K; Veerman A J
Effects of interleukin 3, interleukin 7, and B-cell growth factor on proliferation and drug resistance in vitro in childhood acute lymphoblastic leukemia.
Annals of hematology 1999;78(4):163-71.
-
1999: Rots M G; Pieters R; Peters G J; Noordhuis P; van Zantwijk C H; Kaspers G J; Hählen K; Creutzig U; Veerman A J; Jansen G
Role of folylpolyglutamate synthetase and folylpolyglutamate hydrolase in methotrexate accumulation and polyglutamylation in childhood leukemia.
Blood 1999;93(5):1677-83.
-
1999: Den Boer M L; Pieters R; Kazemier K M; Janka-Schaub G E; Henze G; Creutzig U; Kaspers G J; Kearns P R; Hall A G; Pearson A D; Veerman A J
Different expression of glutathione S-transferase alpha, mu and pi in childhood acute lymphoblastic and myeloid leukaemia.
British journal of haematology 1999;104(2):321-7.
-
1999: Broxterman H J; Sonneveld P; Pieters R; Lankelma J; Eekman C A; Loonen A H; Schoester M; Ossenkoppele G J; Löwenberg B; Pinedo H M; Schuurhuis G J
Do P-glycoprotein and major vault protein (MVP/LRP) expression correlate with in vitro daunorubicin resistance in acute myeloid leukemia?
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1999;13(2):258-65.
-
1999: Rots M G; Pieters R; Kaspers G J; van Zantwijk C H; Noordhuis P; Mauritz R; Veerman A J; Jansen G; Peters G J
Differential methotrexate resistance in childhood T- versus common/preB-acute lymphoblastic leukemia can be measured by an in situ thymidylate synthase inhibition assay, but not by the MTT assay.
Blood 1999;93(3):1067-74.
-
1999: Hegge I R; Kaspers G J; Rots M G; Jansen G; Pieters R; Veerman A J
Lack of cross-resistance between prednisolone and methotrexate in childhood acute lymphoblastic leukemia? A preliminary analysis.
Advances in experimental medicine and biology 1999;457():551-5.
-
1999: Kaspers G J; Zwaan C M; Pieters R; Veerman A J
Cellular drug resistance in childhood acute myeloid leukemia. A mini-review with emphasis on cell culture assays.
Advances in experimental medicine and biology 1999;457():415-21.
-
1999: Pieters R; Kaspers G J; Ramakers-van Woerden N L; den Boer M L; Rots M G; Zwaan C M; Haarman E G; Veerman A J
Resistance testing and mechanisms of resistance in childhood leukemia. Studies from Amsterdam.
Advances in experimental medicine and biology 1999;457():391-5.
-
1999: Haarman E G; Kaspers G J; Pieters R; van Zantwijk C H; Broekema G J; Hählen K; Veerman A J
BCL-2 expression in childhood leukemia versus spontaneous apoptosis, drug induced apoptosis, and in vitro drug resistance.
Advances in experimental medicine and biology 1999;457():325-33.
-
1999: Kearns P; Pieters R; Rottier M M; Veerman A J; Schmiegalow K; Pearson A D; Hall A G
Glutathione in childhood acute leukaemias.
Advances in experimental medicine and biology 1999;457():211-6.
-
1998: Den Boer M L; Pieters R; Veerman A J
Mechanisms of cellular anthracycline resistance in childhood acute leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1998;12(11):1657-70.
-
1998: Mauritz R; Bekkenk M W; Rots M G; Pieters R; Mini E; van Zantwijk C H; Veerman A J; Peters G J; Jansen G
Ex vivo activity of methotrexate versus novel antifolate inhibitors of dihydrofolate reductase and thymidylate synthase against childhood leukemia cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(10):2399-410.
-
1998: Pieters R; den Boer M L; Durian M; Janka G; Schmiegelow K; Kaspers G J; van Wering E R; Veerman A J
Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia--implications for treatment of infants.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1998;12(9):1344-8.
-
1998: Kaspers G J; Pieters R; Van Zantwijk C H; Van Wering E R; Van Der Does-Van Den Berg A; Veerman A J
Prednisolone resistance in childhood acute lymphoblastic leukemia: vitro-vivo correlations and cross-resistance to other drugs.
Blood 1998;92(1):259-66.
-
1998: den Boer M L; Pieters R; Kazemier K M; Janka-Schaub G E; Henze G; Veerman A J
The modulating effect of PSC 833, cyclosporin A, verapamil and genistein on in vitro cytotoxicity and intracellular content of daunorubicin in childhood acute lymphoblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1998;12(6):912-20.
-
1998: den Boer M L; Pieters R; Kazemier K M; Rottier M M; Zwaan C M; Kaspers G J; Janka-Schaub G; Henze G; Creutzig U; Scheper R J; Veerman A J
Relationship between major vault protein/lung resistance protein, multidrug resistance-associated protein, P-glycoprotein expression, and drug resistance in childhood leukemia.
Blood 1998;91(6):2092-8.
-
1997: van den Heuvel-Eibrink M M; van der Holt B; te Boekhorst P A; Pieters R; Schoester M; Löwenberg B; Sonneveld P
MDR 1 expression is an independent prognostic factor for response and survival in de novo acute myeloid leukaemia.
British journal of haematology 1997;99(1):76-83.
-
1997: Kaspers G J; Veerman A J; Pieters R; Van Zantwijk C H; Smets L A; Van Wering E R; Van Der Does-Van Den Berg A
In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia.
Blood 1997;90(7):2723-9.
-
1997: Den Boer M L; Zwaan C M; Pieters R; Kazemier K M; Rottier M M; Flens M J; Scheper R J; Veerman A J
Optimal immunocytochemical and flow cytometric detection of P-gp, MRP and LRP in childhood acute lymphoblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1997;11(7):1078-85.
-
1997: Pieters R; Klumper E; Kaspers G J; Veerman A J
Everything you always wanted to know about cellular drug resistance in childhood acute lymphoblastic leukemia.
Critical reviews in oncology/hematology 1997;25(1):11-26.
-
1996: Kaspers G J; Veerman A J; Popp-Snijders C; Lomecky M; Van Zantwijk C H; Swinkels L M; Van Wering E R; Pieters R
Comparison of the antileukemic activity in vitro of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia.
Medical and pediatric oncology 1996;27(2):114-21.
-
1996: Klumper E; Ossenkoppele G J; Pieters R; Huismans D R; Loonen A H; Rottier A; Westra G; Veerman A J
In vitro resistance to cytosine arabinoside, not to daunorubicin, is associated with the risk of relapse in de novo acute myeloid leukaemia.
British journal of haematology 1996;93(4):903-10.
-
1996: Kaspers G J; Veerman A J; Van Wering E R; Van Der Linden-Schrever B E; Van Zantwijk C H; Van Der Does-Van Den Berg A; Pieters R
Prognostic significance of peanut agglutinin binding in childhood acute lymphoblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1996;10(4):675-81.
-
1995: Kaspers G J; Pieters R; Van Zantwijk C H; Van Wering E R; Veerman A J
Clinical and cell biological features related to cellular drug resistance of childhood acute lymphoblastic leukemia cells.
Leukemia & lymphoma 1995;19(5-6):407-16.
-
1995: Klumper E; Pieters R; Veerman A J; Huismans D R; Loonen A H; Hählen K; Kaspers G J; van Wering E R; Hartmann R; Henze G
In vitro cellular drug resistance in children with relapsed/refractory acute lymphoblastic leukemia.
Blood 1995;86(10):3861-8.
-
1995: Klumper E; Pieters R; Kaspers G J; Huismans D R; Loonen A H; Rottier M M; van Wering E R; van der Does-van den Berg A; Hählen K; Creutzig U
In vitro chemosensitivity assessed with the MTT assay in childhood acute non-lymphoblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1995;9(11):1864-9.
-
1995: Klumper E; Giaccone G; Pieters R; Broekema G; van Ark-Otte J; van Wering E R; Kaspers G J; Veerman A J
Topoisomerase II alpha gene expression in childhood acute lymphoblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1995;9(10):1653-60.
-
1995: Klumper E; Pieters R; den Boer M L; Huismans D R; Loonen A H; Veerman A J
In vitro anthracycline cross-resistance pattern in childhood acute lymphoblastic leukaemia.
British journal of cancer 1995;71(6):1188-93.
-
1995: Kaspers G J; Veerman A J; Pieters R; Van Zantwijk I; Hählen K; Van Wering E R
Drug combination testing in acute lymphoblastic leukemia using the MTT assay.
Leukemia research 1995;19(3):175-81.
-
1995: Kaspers G J; Smets L A; Pieters R; Van Zantwijk C H; Van Wering E R; Veerman A J
Favorable prognosis of hyperdiploid common acute lymphoblastic leukemia may be explained by sensitivity to antimetabolites and other drugs: results of an in vitro study.
Blood 1995;85(3):751-6.
-
1995: Schuurhuis G J; Broxterman H J; Ossenkoppele G J; Baak J P; Eekman C A; Kuiper C M; Feller N; van Heijningen T H; Klumper E; Pieters R
Functional multidrug resistance phenotype associated with combined overexpression of Pgp/MDR1 and MRP together with 1-beta-D-arabinofuranosylcytosine sensitivity may predict clinical response in acute myeloid leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 1995;1(1):81-93.
-
1994: Kaspers G J; Veerman A J; Pieters R; Broekema G J; Huismans D R; Kazemier K M; Loonen A H; Rottier M A; van Zantwijk C H; Hählen K
Mononuclear cells contaminating acute lymphoblastic leukaemic samples tested for cellular drug resistance using the methyl-thiazol-tetrazolium assay.
British journal of cancer 1994;70(6):1047-52.
-
1994: Kaspers G J; Kardos G; Pieters R; Van Zantwijk C H; Klumper E; Hählen K; de Waal F C; van Wering E R; Veerman A J
Different cellular drug resistance profiles in childhood lymphoblastic and non-lymphoblastic leukemia: a preliminary report.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1994;8(7):1224-9.
-
1994: Pieters R; Kaspers G J; Klumper E; van Wering E R; van der Does-van den Berg A; Veerman A J
[Clinical relevance of resistance against cytostatic agents in children with leukemia]
Nederlands tijdschrift voor geneeskunde 1994;138(14):706-12.
-
1994: Kaspers G J; Pieters R; Klumper E; De Waal F C; Veerman A J
Glucocorticoid resistance in childhood leukemia.
Leukemia & lymphoma 1994;13(3-4):187-201.
-
1994: Kaspers G L; Veerman A J; Pieters R; van Zantwijk I; Klumper E; Hählen K; de Waal F C; van Wering E R
In vitro cytotoxicity of mitoxantrone, daunorubicin and doxorubicin in untreated childhood acute leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1994;8(1):24-9.
-
1994: Pieters R; Kaspers G J; Klumper E; Veerman A J
Clinical relevance of in vitro drug resistance testing in childhood acute lymphoblastic leukemia: the state of the art.
Medical and pediatric oncology 1994;22(5):299-308.
-
1994: Veerman A J; Kaspers G J; Pieters R
Cellular drug resistance in childhood leukemia.
Annals of hematology 1994;69 Suppl 1():S31-4.
-
1994: van Oostveen D C; Pieters R; Peters G J; Veerman A J
Purine nucleotide interconversion enzymes in childhood leukemia: relation with cell cycle and clinical outcome.
Advances in experimental medicine and biology 1994;370():209-12.
-
1993: Pieters R; Kaspers G J; van Wering E R; Huismans D R; Loonen A H; Hählen K; Veerman A J
Cellular drug resistance profiles that might explain the prognostic value of immunophenotype and age in childhood acute lymphoblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1993;7(3):392-7.
-
1993: Kaspers G J; Pieters R; Klumper E; de Waal F C; Veerman A J
[The treatment of recurrence in children with acute lymphatic leukemia. Current results and various developments]
Tijdschrift voor kindergeneeskunde 1993;61(1):1-7.
-
1993: Pieters R; Kaspers G J; van Wering E R; Huismans D R; Loonen A H; Hählen K; Veerman A J
Cellular drug sensitivity of immunophenotypic subgroups of childhood acute lymphoblastic leukemia.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1993;131():249-56.
-
1992: Pieters R; Huismans D R; Loonen A H; Peters G J; Hählen K; van der Does-van den Berg A; van Wering E R; Veerman A J
Relation of 5'-nucleotidase and phosphatase activities with immunophenotype, drug resistance and clinical prognosis in childhood leukemia.
Leukemia research 1992;16(9):873-80.
-
1992: Pieters R; Huismans D R; Loonen A H; Peters G J; Hählen K; van der Does-van den Berg A; van Wering E R; Veerman A J
Adenosine deaminase and purine nucleoside phosphorylase in childhood lymphoblastic leukemia: relation with differentiation stage, in vitro drug resistance and clinical prognosis.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1992;6(5):375-80.
-
1992: Pieters R; Huismans D R; Loonen A H; Peters G J; Hählen K; van der Does-van den Berg A; van Wering E R; Veerman A J
Hypoxanthine-guanine phosphoribosyl-transferase in childhood leukemia: relation with immunophenotype, in vitro drug resistance and clinical prognosis.
International journal of cancer. Journal international du cancer 1992;51(2):213-7.
-
1992: Pieters R; Hongo T; Loonen A H; Huismans D R; Broxterman H J; Hählen K; Veerman A J
Different types of non-P-glycoprotein mediated multiple drug resistance in children with relapsed acute lymphoblastic leukaemia.
British journal of cancer 1992;65(5):691-7.
-
1991: Horst E; Radaszkiewicz T; Hooftman-den Otter A; Pieters R; van Dongen J J; Meijer C J; Pals S T
Expression of the leucocyte integrin LFA-1 (CD11a/CD18) and its ligand ICAM-1 (CD54) in lymphoid malignancies is related to lineage derivation and stage of differentiation but not to tumor grade.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1991;5(10):848-53.
-
1991: Pieters R; Huismans D R; Loonen A H; Hählen K; Veerman A J
Cytotoxic effects of vitamin A in combination with vincristine, daunorubicin and 6-thioguanine upon cells from lymphoblastic leukemic patients.
Japanese journal of cancer research : Gann 1991;82(9):1051-5.
-
1991: Kaspers G J; Pieters R; Van Zantwijk C H; De Laat P A; De Waal F C; Van Wering E R; Veerman A J
In vitro drug sensitivity of normal peripheral blood lymphocytes and childhood leukaemic cells from bone marrow and peripheral blood.
British journal of cancer 1991;64(3):469-74.
-
1991: Pieters R; Huismans D R; Loonen A H; Hählen K; van der Does-van den Berg A; van Wering E R; Veerman A J
Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia.
Lancet 1991;338(8764):399-403.
-
1991: Pieters R; Thompson L F; Broekema G J; Huismans D R; Peters G J; Pals S T; Horst E; Hählen K; Veerman A J
Expression of 5'-nucleotidase (CD73) related to other differentiation antigens in leukemias of B-cell lineage.
Blood 1991;78(2):488-92.
-
1990: Pieters R; Loonen A H; Huismans D R; Broekema G J; Dirven M W; Heyenbrok M W; Hählen K; Veerman A J
In vitro drug sensitivity of cells from children with leukemia using the MTT assay with improved culture conditions.
Blood 1990;76(11):2327-36.
-
1990: Horst E; Meijer C J; Radaskiewicz T; van Dongen J J; Pieters R; Figdor C G; Hooftman A; Pals S T
Expression of a human homing receptor (CD44) in lymphoid malignancies and related stages of lymphoid development.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1990;4(5):383-9.
-
1990: Veerman A J; Pieters R
Drug sensitivity assays in leukaemia and lymphoma.
British journal of haematology 1990;74(4):381-4.
-
1989: Pieters R; Taets van Amerongen A H; van Brenk A I; Veerman A J
[Bone necrosis as a sequela of chemotherapy in hematologically malignant disorders]
Nederlands tijdschrift voor geneeskunde 1989;133(43):2117-22.
-
1989: Pieters R; van der Schans-Dop A M; van Brenk A I; Taets van Amerongen A H; Veerman A J
Osteonecrosis following chemotherapy for leukemia.
European journal of haematology 1989;43(3):262-4.
-
1989: Pieters R; Huismans D R; Leyva A; Veerman A J
Comparison of the rapid automated MTT-assay with a dye exclusion assay for chemosensitivity testing in childhood leukaemia.
British journal of cancer 1989;59(2):217-20.
-
1989: Pieters R; Huismans D R; Leyva A; Veerman A J
Sensitivity to purine analogues in childhood leukemia assessed by the automated MTT-assay.
Advances in experimental medicine and biology 1989;253A():447-54.
-
1988: Pieters R; Veerman A J
The role of 5'nucleotidase in therapy-resistance of childhood leukemia.
Medical hypotheses 1988;27(1):77-80.
-
1988: Pieters R; Huismans D R; Leyva A; Veerman A J
Adaptation of the rapid automated tetrazolium dye based (MTT) assay for chemosensitivity testing in childhood leukemia.
Cancer letters 1988;41(3):323-32.
-
1988: van den Doel L J; Pieters R; Huismans D R; van Zantwijk C H; Loonen A H; Broekema G J; de Waal F C; Veerman A J
Immunological phenotype of lymphoid cells in regenerating bone marrow of children after treatment for acute lymphoblastic leukemia.
European journal of haematology 1988;41(2):170-5.
-
1988: van Zanten T E; Golding R P; Taets van Amerongen A H; Pieters R; Veerman A J
Nuclear magnetic resonance imaging of bone marrow in childhood leukaemia.
Clinical radiology 1988;39(1):77-81.
-
1987: Pieters R; van Brenk A I; Veerman A J; van Amerongen A H; van Zanten T E; Golding R P
Bone marrow magnetic resonance studies in childhood leukemia. Evaluation of osteonecrosis.
Cancer 1987;60(12):2994-3000.
-
1987: Pieters R; van Brenk A I; Veerman A J; Taets van Amerongen A H; van Zanten T E; Golding R P
[Electron spin resonance tomography of the musculoskeletal system]
Nederlands tijdschrift voor geneeskunde 1987;131(36):1586.
-
1987: Pieters R; Veerman A J
Prognostic significance of acid alpha-naphthyl acetate esterase and acid phosphatase in childhood acute lymphoblastic leukemia.
Leukemia research 1987;11(11):995-9.
Sign-in to see more
